[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States High Dose Radiation (HDR) Monotherapy Market Report 2016

September 2016 | 116 pages | ID: U1D87342553EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of High Dose Radiation (HDR) Monotherapy

Revenue, means the sales value of High Dose Radiation (HDR) Monotherapy

This report studies sales (consumption) of High Dose Radiation (HDR) Monotherapy in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • Pfizer Inc. (USA)
  • Abbott Laboratories (USA)
  • Genentech Inc. (USA)
  • GlaxoSmithKline Plc (UK)
  • Immunomedics, Inc. (USA)
  • Indevus Pharmaceuticals Inc. (USA)
  • Novartis AG (Switzerland)
  • OSI Pharmaceuticals, Inc. (USA)
  • Paladin Labs Inc. (Canada)
  • ALZA Corporation (USA)
  • Amgen Inc. (USA)
  • AstraZeneca PLC (UK)
  • Medimmune, LLC (USA)
  • Bristol-Myers Squibb Company (USA)
  • Cell Genesys Inc. (USA)
  • Dendreon Corporation (USA)
  • EUSA Pharma, (USA) Inc. (USA)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Progenics Pharmaceuticals, Inc. (USA)
  • Sanofi-Aventis SA (France)
  • Spectrum Pharmaceuticals, Inc. (USA)
  • Takeda Pharmaceutical Company Limited (Japan)
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by applications, this report focuses on sales, market share and growth rate of High Dose Radiation (HDR) Monotherapy in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
United States High Dose Radiation (HDR) Monotherapy Market Report 2016

1 HIGH DOSE RADIATION (HDR) MONOTHERAPY OVERVIEW

1.1 Product Overview and Scope of High Dose Radiation (HDR) Monotherapy
1.2 Classification of High Dose Radiation (HDR) Monotherapy
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of High Dose Radiation (HDR) Monotherapy
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 USA Market Size Sales (Value) and Revenue (Volume) of High Dose Radiation (HDR) Monotherapy (2011-2021)
  1.4.1 USA High Dose Radiation (HDR) Monotherapy Sales and Growth Rate (2011-2021)
  1.4.2 USA High Dose Radiation (HDR) Monotherapy Revenue and Growth Rate (2011-2021)

2 USA HIGH DOSE RADIATION (HDR) MONOTHERAPY COMPETITION BY MANUFACTURERS

2.1 USA High Dose Radiation (HDR) Monotherapy Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA High Dose Radiation (HDR) Monotherapy Revenue and Share by Manufactures (2015 and 2016)
2.3 USA High Dose Radiation (HDR) Monotherapy Average Price by Manufactures (2015 and 2016)
2.4 High Dose Radiation (HDR) Monotherapy Market Competitive Situation and Trends
  2.4.1 High Dose Radiation (HDR) Monotherapy Market Concentration Rate
  2.4.2 High Dose Radiation (HDR) Monotherapy Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 USA HIGH DOSE RADIATION (HDR) MONOTHERAPY SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 USA High Dose Radiation (HDR) Monotherapy Sales and Market Share by Type (2011-2016)
3.2 USA High Dose Radiation (HDR) Monotherapy Revenue and Market Share by Type (2011-2016)
3.3 USA High Dose Radiation (HDR) Monotherapy Price by Type (2011-2016)
3.4 USA High Dose Radiation (HDR) Monotherapy Sales Growth Rate by Type (2011-2016)

4 USA HIGH DOSE RADIATION (HDR) MONOTHERAPY SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 USA High Dose Radiation (HDR) Monotherapy Sales and Market Share by Application (2011-2016)
4.2 USA High Dose Radiation (HDR) Monotherapy Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 USA HIGH DOSE RADIATION (HDR) MONOTHERAPY MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer Inc. (USA)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 High Dose Radiation (HDR) Monotherapy Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Abbott Laboratories (USA)
  5.2.2 High Dose Radiation (HDR) Monotherapy Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Abbott Laboratories (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Genentech Inc. (USA)
  5.3.2 High Dose Radiation (HDR) Monotherapy Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Genentech Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 GlaxoSmithKline Plc (UK)
  5.4.2 High Dose Radiation (HDR) Monotherapy Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 GlaxoSmithKline Plc (UK) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Immunomedics, Inc. (USA)
  5.5.2 High Dose Radiation (HDR) Monotherapy Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Immunomedics, Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Indevus Pharmaceuticals Inc. (USA)
  5.6.2 High Dose Radiation (HDR) Monotherapy Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Indevus Pharmaceuticals Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Novartis AG (Switzerland)
  5.7.2 High Dose Radiation (HDR) Monotherapy Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Novartis AG (Switzerland) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 OSI Pharmaceuticals, Inc. (USA)
  5.8.2 High Dose Radiation (HDR) Monotherapy Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 OSI Pharmaceuticals, Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Paladin Labs Inc. (Canada)
  5.9.2 High Dose Radiation (HDR) Monotherapy Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Paladin Labs Inc. (Canada) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 ALZA Corporation (USA)
  5.10.2 High Dose Radiation (HDR) Monotherapy Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 ALZA Corporation (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Amgen Inc. (USA)
5.12 AstraZeneca PLC (UK)
5.13 Medimmune, LLC (USA)
5.14 Bristol-Myers Squibb Company (USA)
5.15 Cell Genesys Inc. (USA)
5.16 Dendreon Corporation (USA)
5.17 EUSA Pharma, (USA) Inc. (USA)
5.18 F. Hoffmann-La Roche Ltd. (Switzerland)
5.19 Progenics Pharmaceuticals, Inc. (USA)
5.20 Sanofi-Aventis SA (France)
5.21 Spectrum Pharmaceuticals, Inc. (USA)
5.22 Takeda Pharmaceutical Company Limited (Japan)

6 HIGH DOSE RADIATION (HDR) MONOTHERAPY MANUFACTURING COST ANALYSIS

6.1 High Dose Radiation (HDR) Monotherapy Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of High Dose Radiation (HDR) Monotherapy

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 High Dose Radiation (HDR) Monotherapy Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of High Dose Radiation (HDR) Monotherapy Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 USA HIGH DOSE RADIATION (HDR) MONOTHERAPY MARKET FORECAST (2016-2021)

10.1 USA High Dose Radiation (HDR) Monotherapy Sales, Revenue Forecast (2016-2021)
10.2 USA High Dose Radiation (HDR) Monotherapy Sales Forecast by Type (2016-2021)
10.3 USA High Dose Radiation (HDR) Monotherapy Sales Forecast by Application (2016-2021)
10.4 High Dose Radiation (HDR) Monotherapy Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of High Dose Radiation (HDR) Monotherapy
Table Classification of High Dose Radiation (HDR) Monotherapy
Figure USA Sales Market Share of High Dose Radiation (HDR) Monotherapy by Type in 2015
Table Application of High Dose Radiation (HDR) Monotherapy
Figure USA Sales Market Share of High Dose Radiation (HDR) Monotherapy by Application in 2015
Figure USA High Dose Radiation (HDR) Monotherapy Sales and Growth Rate (2011-2021)
Figure USA High Dose Radiation (HDR) Monotherapy Revenue and Growth Rate (2011-2021)
Table USA High Dose Radiation (HDR) Monotherapy Sales of Key Manufacturers (2015 and 2016)
Table USA High Dose Radiation (HDR) Monotherapy Sales Share by Manufacturers (2015 and 2016)
Figure 2015 High Dose Radiation (HDR) Monotherapy Sales Share by Manufacturers
Figure 2016 High Dose Radiation (HDR) Monotherapy Sales Share by Manufacturers
Table USA High Dose Radiation (HDR) Monotherapy Revenue by Manufacturers (2015 and 2016)
Table USA High Dose Radiation (HDR) Monotherapy Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA High Dose Radiation (HDR) Monotherapy Revenue Share by Manufacturers
Table 2016 USA High Dose Radiation (HDR) Monotherapy Revenue Share by Manufacturers
Table USA Market High Dose Radiation (HDR) Monotherapy Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market High Dose Radiation (HDR) Monotherapy Average Price of Key Manufacturers in 2015
Figure High Dose Radiation (HDR) Monotherapy Market Share of Top 3 Manufacturers
Figure High Dose Radiation (HDR) Monotherapy Market Share of Top 5 Manufacturers
Table USA High Dose Radiation (HDR) Monotherapy Sales by Type (2011-2016)
Table USA High Dose Radiation (HDR) Monotherapy Sales Share by Type (2011-2016)
Figure USA High Dose Radiation (HDR) Monotherapy Sales Market Share by Type in 2015
Table USA High Dose Radiation (HDR) Monotherapy Revenue and Market Share by Type (2011-2016)
Table USA High Dose Radiation (HDR) Monotherapy Revenue Share by Type (2011-2016)
Figure Revenue Market Share of High Dose Radiation (HDR) Monotherapy by Type (2011-2016)
Table USA High Dose Radiation (HDR) Monotherapy Price by Type (2011-2016)
Figure USA High Dose Radiation (HDR) Monotherapy Sales Growth Rate by Type (2011-2016)
Table USA High Dose Radiation (HDR) Monotherapy Sales by Application (2011-2016)
Table USA High Dose Radiation (HDR) Monotherapy Sales Market Share by Application (2011-2016)
Figure USA High Dose Radiation (HDR) Monotherapy Sales Market Share by Application in 2015
Table USA High Dose Radiation (HDR) Monotherapy Sales Growth Rate by Application (2011-2016)
Figure USA High Dose Radiation (HDR) Monotherapy Sales Growth Rate by Application (2011-2016)
Table Pfizer Inc. (USA) Basic Information List
Table Pfizer Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales Market Share (2011-2016)
Table Abbott Laboratories (USA) Basic Information List
Table Abbott Laboratories (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Laboratories (USA) High Dose Radiation (HDR) Monotherapy Sales Market Share (2011-2016)
Table Genentech Inc. (USA) Basic Information List
Table Genentech Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genentech Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc (UK) Basic Information List
Table GlaxoSmithKline Plc (UK) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc (UK) High Dose Radiation (HDR) Monotherapy Sales Market Share (2011-2016)
Table Immunomedics, Inc. (USA) Basic Information List
Table Immunomedics, Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Immunomedics, Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales Market Share (2011-2016)
Table Indevus Pharmaceuticals Inc. (USA) Basic Information List
Table Indevus Pharmaceuticals Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Indevus Pharmaceuticals Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales Market Share (2011-2016)
Table Novartis AG (Switzerland) Basic Information List
Table Novartis AG (Switzerland) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis AG (Switzerland) High Dose Radiation (HDR) Monotherapy Sales Market Share (2011-2016)
Table OSI Pharmaceuticals, Inc. (USA) Basic Information List
Table OSI Pharmaceuticals, Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table OSI Pharmaceuticals, Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales Market Share (2011-2016)
Table Paladin Labs Inc. (Canada) Basic Information List
Table Paladin Labs Inc. (Canada) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Paladin Labs Inc. (Canada) High Dose Radiation (HDR) Monotherapy Sales Market Share (2011-2016)
Table ALZA Corporation (USA) Basic Information List
Table ALZA Corporation (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table ALZA Corporation (USA) High Dose Radiation (HDR) Monotherapy Sales Market Share (2011-2016)
Table Amgen Inc. (USA) Basic Information List
Table Amgen Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales Market Share (2011-2016)
Table AstraZeneca PLC (UK) Basic Information List
Table AstraZeneca PLC (UK) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table AstraZeneca PLC (UK) High Dose Radiation (HDR) Monotherapy Sales Market Share (2011-2016)
Table Medimmune, LLC (USA) Basic Information List
Table Medimmune, LLC (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Medimmune, LLC (USA) High Dose Radiation (HDR) Monotherapy Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Company (USA) Basic Information List
Table Bristol-Myers Squibb Company (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Company (USA) High Dose Radiation (HDR) Monotherapy Sales Market Share (2011-2016)
Table Cell Genesys Inc. (USA) Basic Information List
Table Cell Genesys Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cell Genesys Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales Market Share (2011-2016)
Table Dendreon Corporation (USA) Basic Information List
Table Dendreon Corporation (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dendreon Corporation (USA) High Dose Radiation (HDR) Monotherapy Sales Market Share (2011-2016)
Table EUSA Pharma, (USA) Inc. (USA) Basic Information List
Table EUSA Pharma, (USA) Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table EUSA Pharma, (USA) Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales Market Share (2011-2016)
Table F. Hoffmann-La Roche Ltd. (Switzerland) Basic Information List
Table F. Hoffmann-La Roche Ltd. (Switzerland) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table F. Hoffmann-La Roche Ltd. (Switzerland) High Dose Radiation (HDR) Monotherapy Sales Market Share (2011-2016)
Table Progenics Pharmaceuticals, Inc. (USA) Basic Information List
Table Progenics Pharmaceuticals, Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Progenics Pharmaceuticals, Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales Market Share (2011-2016)
Table Sanofi-Aventis SA (France) Basic Information List
Table Sanofi-Aventis SA (France) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi-Aventis SA (France) High Dose Radiation (HDR) Monotherapy Sales Market Share (2011-2016)
Table Spectrum Pharmaceuticals, Inc. (USA) Basic Information List
Table Spectrum Pharmaceuticals, Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Spectrum Pharmaceuticals, Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales Market Share (2011-2016)
Table Takeda Pharmaceutical Company Limited (Japan) Basic Information List
Table Takeda Pharmaceutical Company Limited (Japan) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Takeda Pharmaceutical Company Limited (Japan) High Dose Radiation (HDR) Monotherapy Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of High Dose Radiation (HDR) Monotherapy
Figure Manufacturing Process Analysis of High Dose Radiation (HDR) Monotherapy
Figure High Dose Radiation (HDR) Monotherapy Industrial Chain Analysis
Table Raw Materials Sources of High Dose Radiation (HDR) Monotherapy Major Manufacturers in 2015
Table Major Buyers of High Dose Radiation (HDR) Monotherapy
Table Distributors/Traders List
Figure USA High Dose Radiation (HDR) Monotherapy Production and Growth Rate Forecast (2016-2021)
Figure USA High Dose Radiation (HDR) Monotherapy Revenue and Growth Rate Forecast (2016-2021)
Table USA High Dose Radiation (HDR) Monotherapy Production Forecast by Type (2016-2021)
Table USA High Dose Radiation (HDR) Monotherapy Consumption Forecast by Application (2016-2021)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories